openPR Logo
Press release

Swine Flu Drugs Market to Expand with Significant CAGR by 2025

04-10-2018 05:54 PM CET | Health & Medicine

Press release from: Transparency Market Research

Swine Flu Drugs Market to Expand with Significant CAGR by 2025

Swine flu is a respiratory disease originally transmitted from pigs to human beings, and presently even from one person to another. Symptoms of swine flu include vomiting, nausea, sore throat, runny nose, sneezing, coughing, diarrhea, chills, headaches, lethargy, fever, and lack of appetite. Swine flu cases become more prevalent during monsoon and summer seasons. People with weak or compromised immune systems, heart problems, or and diabetics, besides pregnant women and children, are at high-risk of swine flu. The incubation period of swine flu is approximately one day to four days. Diagnosis of swine flu is done in labs through the identification of antigens specifically associated with the H1N1 type A influenza virus. Drugs available for the treatment of swine flu include Tamiflu, Oseltamivir, Relenza, Zanamivir, and Peramivir. However, among swine flu drugs, Peramivir has not been approved by the FDA for the treatment of swine flu.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41309

Global Swine Flu Drugs Market: Drivers and Restraints

Swine flu virus was for the first time isolated from pigs in the U.S. in 1930 and has been recognized to have caused infections among pigs all over the world. People who are closely associated with pigs, such as pork processors or farmers, tend to get affected with swine flu drugs. In many cases swine flu drugs cross infections that is human flu virus to pigs or swine virus to human beings has remained in the local areas. However, in Mexico, in April 2009, there was an outbreak (pandemic) of swine flu due to infection with the H1N1 virus. The term H1N1 flu was coined by the investigators as it was mainly found infecting human beings and exhibited two main surface antigens, H1 (hem agglutinin type 1) and N1 (neuraminidase type1). Swine flu has been spreading all over the world. Increase in prevalence of swine flu drives the growth of the Swine Flu Drugs Market. In Asia, for instance, India recorded approximately 1,094 deaths in 2017 caused by swine flu, as per a BBC news report. The report also stated that there were a total of 22,186 cases of swine flu testified across India.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=41309

Global Swine Flu Drugs Market: Key Segments

The swine flu drugs market can be segmented on the basis of drug class, dosage form, distribution channel, and region. Based on drug class, the swine flu drugs market can be categorized into neuraminidase inhibitors and inhaled anti-infectives. In terms of dosage form, the swine flu drugs market can be classified into capsule and oral powder inhalation. Based on distribution channel, the swine flu drugs market can be divided into online pharmacies, retail pharmacies, and hospital pharmacies. The hospital pharmacies segment was estimated to dominate the swine flu drugs market in 2016 owing to the wide availability of swine flu drugs in them.

Geographically, the swine flu drugs market can be divided into Latin America, Asia Pacific, Europe, North America, and Middle East & Africa. Asia Pacific accounted for the dominant swine flu drugs market share in 2016 due to increase in prevalence of swine flu in the region. Europe constituted the next leading share of the swine flu drugs market in 2016 owing to rise in infectious diseases among people with certain long-term health conditions, pregnant women, young children, and geriatric population. North America also held a significant share of the swine flu drugs market in 2016, due to increasing prevalence of the swine flu in the region. The swine flu drugs market in Middle East & Africa and Latin America is anticipated to expand during the forecast period.

Global Swine Flu Drugs Market: Key Players

Key players operating in the swine flu drugs market include Gilead Sciences, Inc., Genentech, Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline, and BioCryst Pharmaceuticals, Inc.

View Report -

https://www.transparencymarketresearch.com/swine-flu-drugs-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Swine Flu Drugs Market to Expand with Significant CAGR by 2025 here

News-ID: 1010450 • Views:

More Releases from Transparency Market Research

Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnostic Advancements, Oral Drug Innovations, and Rising Disease Awareness | TMR
Acromegaly Treatment Market to Reach USD 3.1 Billion by 2035, Driven by Diagnost …
The global Acromegaly Treatment Market is experiencing a significant transformation as improved early diagnosis, innovative therapeutic formulations, and regulatory support converge to expand patient access and drive substantial growth. According to the latest industry analysis, the global market, valued at US$ 1.5 billion in 2024, is projected to reach US$ 3.1 billion by 2035, progressing at a CAGR of 6.7% from 2025 to 2035. Gain a preview of important insights from
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, AI/ML Bioinformatics and Portable DNA Devices Transform Criminal Investigations | TMR
Forensic Genomics Market Projected to Surge to USD 2.4 Billion by 2035 as NGS, A …
The global Forensic Genomics Market is undergoing a period of accelerated transformation and expansion as next-generation sequencing (NGS), advanced PCR workflows, and AI/ML-driven bioinformatics redefine the capabilities of modern forensic investigations. According to the latest industry analysis, the market-valued at US$ 0.5 billion in 2024-is projected to reach approximately US$ 2.4 billion by 2035, expanding at a compound annual growth rate (CAGR) of 14.5% between 2025 and 2035. Access key findings
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for High-Load, High-Precision Actuation Systems Accelerates Worldwide | TMR
Planetary Roller Screw Market to Reach USD 1.1 Billion by 2035 as Demand for Hig …
The global Planetary Roller Screw Market is poised for substantial expansion over the next decade, driven by rising demand for high-load, high-precision performance in harsh industrial environments, rapid technological advancements, and the ongoing global shift toward electrified and automated systems. According to the latest industry intelligence, the market-valued at US$ 610.0 Mn in 2024-is projected to reach US$ 1,105.0 Mn by 2035, advancing at a compound annual growth rate (CAGR)
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven by Sustainability Initiatives, Regulatory Compliance, and Rising Industrial Demand
Chemical Absorbent Cotton Market Set to Reach USD 600.1 Million by 2035 Driven b …
The global Chemical Absorbent Cotton Market is entering a phase of sustained expansion, backed by rapid industrialization, strengthened environmental regulations, and growing adoption of biodegradable absorbent solutions across healthcare, chemical handling, automotive, and industrial safety applications. According to the latest industry analysis, the global market-valued at US$ 340.0 million in 2024-is projected to reach US$ 600.1 million by 2035, expanding at a CAGR of 5.4% from 2025 to 2035. Access key

All 5 Releases


More Releases for Swine

Rising Prevalence Of Swine Diseases Fuels Growth In Swine Vaccine Market: Critic …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations. Swine Vaccines Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for swine vaccines has seen robust growth in the past few years. The market size is set to increase from $2.18 billion in 2024 to $2.38 billion in 2025, representing a compound annual growth rate (CAGR) of 8.9%.
Primary Catalyst Driving Swine Vaccines Market Evolution in 2025: Rising Prevale …
What combination of drivers is leading to accelerated growth in the swine vaccines market? The surge in swine disease occurrence is predicted to fuel the growth of the swine vaccine market. Swine disease can be described as any deviation from an organism's normal physiological or morphological state, usually coupled with various disease symptoms like pseudorabies, influenza. Swine vaccines are highly effective in battling the escalating swine disease incidents by activating the
Primary Catalyst Driving Swine Vaccines Market Evolution in 2025: Rising Prevale …
What combination of drivers is leading to accelerated growth in the swine vaccines market? The surge in swine disease occurrence is predicted to fuel the growth of the swine vaccine market. Swine disease can be described as any deviation from an organism's normal physiological or morphological state, usually coupled with various disease symptoms like pseudorabies, influenza. Swine vaccines are highly effective in battling the escalating swine disease incidents by activating the
Swine Production Management Software Market Size Analysis by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Swine Production Management Software market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period. As the cattle sector embraces digital solutions for increasing efficiency and production, the market for swine production management software is expanding quickly.
Shaping the Swine Artificial Insemination Market in 2025: Combined Technical Sol …
How Big Is the Swine Artificial Insemination Market Expected to Be, and What Will Its Growth Rate Be?_x000D_ Over recent years, the swine artificial insemination market has experienced robust growth. The market, which is projected to increase from $1.86 billion in 2024 to $2.01 billion in 2025, will rise at a compound annual growth rate (CAGR) of 7.9%. Factors driving growth during the historic period include heightened demand for premium-grade pork,
H1N1 (Swine Influenza) - Drug Pipeline Landscape, 2022
Global Insight Services have recently published a report on H1N1 (Swine Influenza) Pipeline landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The H1N1 flu (swine flu) is primarily caused by the H1N1 strain of the flu (influenza) virus. It is a communicable viral illness causing upper and lower respiratory tract infections. Swine flu H1N1 infects the cells that line